Isatin and its derivatives have garnered significant interest in medicinal chemistry due to their diverse pharmacological activities, including anticancer, antiviral, and antimicrobial effects. This study investigates five 3-monosubstituted isatin derivatives—IA, I4AM, I2AP, I3AP, and I4AP—using the SwissADME platform to evaluate their drug-like properties. The derivatives were analyzed for molecular weight, lipophilicity, water solubility, and adherence to drug-likeness criteria, including Lipinski's Rule of Five and other established filters. The derivatives exhibited favorable molecular weights and topological polar surface areas, suggesting good membrane permeability. Lipophilicity assessments indicated moderate values, beneficial for absorption and distribution, while water solubility predictions varied across models, emphasizing the need for experimental validation. All compounds complied with multiple drug-likeness rules, with bioavailability scores suggesting moderate oral potential. This comprehensive in silico analysis highlights the potential of these isatin derivatives as promising drug candidates. Future studies should focus on synthesizing these compounds and validating their pharmacokinetic and therapeutic profiles in biological systems.
Sinha S, Vohora D. Chapter 2. Drug Discovery and Development: An Overview. In: Vohora D, Singh G, editors. Pharmaceutical Medicine and Translational Clinical Research. Academic Press; 2018. pp. 19-32.
Mateev E, Irfan A, Mateeva A, Kondeva-Burdina M, Georgieva M, Zlatkov A. In silico and in vitro screening of pyrrole-based Hydrazide-Hydrazones as novel acetylcholinesterase inhibitors. Pharmacia. 2024;71:1-7. doi: 10.3897/pharmacia.71.e114120.
Sliwoski G, Kothiwale S, Meiler J, Lowe EW Jr. Computational methods in drug discovery. Pharmacol Rev. 2013 Dec 31;66(1):334-95. doi: 10.1124/pr.112.007336.
Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017 Mar 3;7:42717. doi: 10.1038/srep42717.
Kaminskyy D, Khyluk D, Vasylenko O, Zaprutko L, Lesyk R. A facile synthesis and anticancer activity evaluation of spiro[thiazolidinone-isatin] conjugates. Sci Pharm. 2011 Oct-Dec;79(4):763-77. doi: 10.3797/scipharm.1109-14.
Premanathan M, Radhakrishnan S, Kulangiappar K, Singaravelu G, Thirumalaiarasu V, Sivakumar T, et al. Antioxidant & anticancer activities of isatin (1H-indole-2,3-dione), isolated from the flowers of Couroupita guianensis Aubl. Indian J Med Res. 2012 Nov;136(5):822-6.
Rossi A, Stagno C, Piperno A, Iraci N, Panseri S, Montesi M, M. et al. Anticancer activity and morphological analysis of Pt (II) complexes: Their DFT approach, docking simulation, and ADME‐Tox profiling. Appl Organomet Chem. 2024;38:e7403. doi:10.1002/aoc.7403.
Elsaman T, Mohamed MS, Eltayib EM, Abdel-Aziz HA, Abdalla AE, Munir MU, et al. Isatin derivatives as broad-spectrum antiviral agents: the current landscape. Med Chem Res. 2022;31(2):244-73. doi: 10.1007/s00044-021-02832-4.
Bari S, Patel J, Talele G, Patel A, Sarangapani M. Synthesis and antimicrobial activity of some new isatin derivatives. Iran J Pharm Res. 2006;5(4):249-54.
Bonvicini F, Locatelli A, Morigi R, Leoni A, Gentilomi GA. Isatin Bis-Indole and Bis-Imidazothiazole Hybrids: Synthesis and Antimicrobial Activity. Molecules. 2022 Sep 7;27(18):5781. doi: 10.3390/molecules27185781.
Aboul-Fadl T, Bin-Jubair FA. Anti-tubercular activity of isatin derivatives. Int J Res Pharm Sci. 2010;1(20):113-26.
Gandhi PV, Burande SR, Charde MS, Chakole RD. A review on isatin and its derivatives: synthesis, reactions and applications. J Adv Sci Res. 2021;12(4):01-11. doi:10.55218/JASR/2021.12401.
Khan FA, Maalik A, Noor T, Zaidi A, Farooq U, Bukhari SM. Advances in Pharmacology of Isatin and its Derivatives: A Review. Trop J Pharm Res. 2015;14(10):1937-42. doi:10.4314/tjpr.v14i10.28.
Pandeya SN, Sriram D, Yogeeswari P, Stables JP. Anticonvulsant and neurotoxicity evaluation of 5-(un)-substituted isatinimino derivatives. Pharmazie. 2001 Nov;56(11):875-6.
Sridhar SK, Pandeya SN, Stables JP, Ramesh A. Anticonvulsant activity of hydrazones, Schiff and Mannich bases of isatin derivatives. Eur J Pharm Sci. 2002 Aug;16(3):129-32. doi: 10.1016/s0928-0987(02)00077-5.
Verma M, Pandeya SN, Singh KN, Stables JP. Anticonvulsant activity of Schiff bases of isatin derivatives. Acta Pharm. 2004 Mar;54(1):49-56.
Lipinski CA. Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol. 2004 Dec;1(4):337-41. doi: 10.1016/j.ddtec.2004.11.007.
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):3-26. doi: 10.1016/s0169-409x(00)00129-0.
Ghose AK, Viswanadhan VN, Wendoloski JJ. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. J Comb Chem. 1999 Jan;1(1):55-68. doi: 10.1021/cc9800071.
Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD. Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem. 2002 Jun 6;45(12):2615-23. doi: 10.1021/jm020017n.
Egan WJ, Merz KM Jr, Baldwin JJ. Prediction of drug absorption using multivariate statistics. J Med Chem. 2000 Oct 19;43(21):3867-77. doi: 10.1021/jm000292e.
Muegge I, Heald SL, Brittelli D. Simple selection criteria for drug-like chemical matter. J Med Chem. 2001 Jun 7;44(12):1841-6. doi: 10.1021/jm015507e.
Arnott JA, Planey SL. The influence of lipophilicity in drug discovery and design. Expert Opin Drug Discov. 2012 Oct;7(10):863-75. doi: 10.1517/17460441.2012.714363.
Xu MQ, Zhong T, Yao X, Li ZY, Li H, Wang JR, et al X. Effect of XlogP and hansen solubility parameters on the prediction of small molecule modified docetaxel, doxorubicin and irinotecan conjugates forming stable nanoparticles. Drug Deliv. 2021 Dec;28(1):1603-1615. doi: 10.1080/10717544.2021.1958107.
Wildman SA, Crippen GM. Prediction of Physicochemical Parameters by Atomic Contributions. J Chem Inf Comput Sci. 1999;39(5):868–73. doi:10.1021/ci990307l.
Moriguchi I, Hirono S, Liu K, Nakagomi I, Matsushita Y. Simple Method of Calculating Octanol/Water Partition Coefficient. Chem Pharm Bull. 1992;40(1):127-30. doi: 10.1248/cpb.40.127.
Moriguchi I, Hirono S, Nakagome I, Hirano H. Comparison of Reliability of log P Values for Drugs Calculated by Several Methods. Chem Pharm Bull. 1994;42(4):976-8. doi: 10.1248/cpb.42.976.
Delaney JS. ESOL: estimating aqueous solubility directly from molecular structure. J Chem Inf Comput Sci. 2004 May-Jun;44(3):1000-5. doi: 10.1021/ci034243x.
Ali J, Camilleri P, Brown MB, Hutt AJ, Kirton SB. Revisiting the general solubility equation: in silico prediction of aqueous solubility incorporating the effect of topographical polar surface area. J Chem Inf Model. 2012 Feb 27;52(2):420-8. doi: 10.1021/ci200387c.
Email this article (Login required) 
